Long-term Outcomes of Radical Prostatectomy versus Radiation Therapy for High- and Very High-Risk Localized Prostate Cancer: An IPTW Analysis from a Multi-center Asian Database
This multi-center Asian study utilizing inverse probability of treatment weighting demonstrates that radical prostatectomy provides significantly superior overall and cancer-specific survival outcomes compared to radiation therapy for patients with high- and very high-risk localized prostate cancer.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For men diagnosed with cancer that is confined to the prostate gland, doctors have long debated the best way to stop the disease from returning. Two main paths exist: removing the entire prostate through surgery, or using powerful beams of radiation to destroy the cancer cells from the outside. Both approaches are standard, yet they carry different risks and recovery stories. The question of which method offers the best long-term protection has been studied extensively in Western countries, but a clear answer has remained elusive, particularly for patients of Asian descent. This uncertainty matters because biological differences and varying healthcare systems can influence how a disease behaves and how a body responds to treatment. When the cancer is aggressive and classified as high-risk, the stakes are even higher, as the disease is more likely to spread if not controlled immediately and effectively.
A team of researchers from Taiwan set out to clarify this picture by looking at real-world outcomes for thousands of Asian men facing these difficult choices. They focused specifically on patients with high-risk and very high-risk localized prostate cancer, a group where the cancer cells are more likely to be dangerous but have not yet spread to distant parts of the body. The team gathered data from a massive medical database spanning more than a decade, tracking 1,641 men who had received either surgery or radiation as their primary treatment. To ensure a fair comparison, the researchers used a sophisticated statistical method to balance the groups, effectively matching men who were similar in age and overall health so that the only major difference was the treatment they received. This approach helped them see past the natural differences that often skew medical studies, such as the tendency for surgeons to operate on younger, healthier patients while radiation is often chosen for older men with other health issues.
The results of this analysis pointed toward a distinct advantage for surgery in this specific population. For men with high-risk disease, those who underwent radical prostatectomy, the surgical removal of the prostate, lived longer and were less likely to die from their cancer compared to those who received radiation therapy. This benefit held true even after the researchers adjusted for all the differences between the patient groups. The gap widened for men with very high-risk disease, where surgery showed a significant and consistent survival advantage over radiation at both ten and twelve years after treatment. The data also revealed that patients who started with radiation were more likely to need additional hormone-blocking treatments later on, suggesting that the radiation alone was sometimes less effective at keeping the cancer under control in the long run.
These findings do not suggest that radiation is a failed treatment, but they do indicate that for Asian men with aggressive, localized prostate cancer, surgery may offer a more robust path to long-term survival. The study highlights that when patients are carefully selected and deemed fit for an operation, removing the prostate can provide a stronger shield against the disease than radiation alone. While the researchers acknowledge that their study was observational and not a randomized trial, the consistency of the results across different risk levels and the rigorous methods used to balance the data provide strong evidence for doctors and patients to consider. However, because this was a retrospective study, the findings should be interpreted as associations rather than proof of a direct cause-and-effect relationship, and some hidden factors influencing the results may still remain. In the complex landscape of treating aggressive prostate cancer, this large-scale look at Asian patients adds a crucial piece to the puzzle, suggesting that for many, the scalpel may be the more reliable tool for securing a future free of the disease.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.